An ancient molecule that existed long before the circulatory system evolved has been found to support cancer immunotherapy.

Please be advised that this call is being recorded at the company's request, and a replay will be available on the company's website. I'll now turn the call over to Jennifer Williams, Investor ...

Earnings call Omeros delivered $9.9M in net revenue in Q1 2026 from the launch of YARTEMLEA, with strong early adoption and cash flow positivity despite a mid-January launch. Adjusted net loss was $17 ...

Host Brian Schroer, MD, interviews Sathya Areti, MD, about her case study presented at ACAAI 2025. A 4-year-old boy with recurrent intensive care unit (ICU) admissions for lower respiratory tract ...

Treatment for chronic inflammatory demyelinating polyneuropathy (CIDP), a chronic autoimmune condition that affects the protective layer around your nerves, usually starts with one of three options.

Glycans can enhance, dampen or redirect protein activity. Glycan modification can alter size, charge and geometry, shield an enzyme from degradation, help a hormone find its receptor or steer an ...

The complement lectin pathway is thought to be a key player in renal ischemia–reperfusion injury (IRI), a frequent issue after kidney transplantation. IRI can result in graft failure and increased ...

Complement activation protects against infection but also contributes to pathological mechanisms in a range of clinical conditions such as autoimmune diseases and transplant rejection.

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Article Views are the COUNTER-compliant sum of full text article downloads since ...

OMS906, a MASP-3 inhibitor, demonstrated clinical efficacy in a proof-of-concept study for patients with paroxysmal nocturnal hemoglobinuria, according to an interim analysis presented at the 2023 EHA ...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the Office of New Drugs (OND) of the U.S. Food and Drug Administration (FDA) has reached a decision on the company’s ...